Clinical Trials › NCT05805839
Enrolling by InvitationPhase 2
A Study of Imaging in Demyelinating Diseases
Sponsored by Mayo Clinic
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 200
Target enrollment
1
U.S. states
Jul 2023
Start date
May 2028
Expected completion
Interventions / Treatments
C-11 ER176 RadiotracerC11 Pittsburgh Compound BPET/CT scanMRI
Conditions studied
Multiple Sclerosis
Where this trial is running (1 site)
Minnesota1 site
Rochester
Participating MS centers on MS Buddy (1)
Mayo Clinic Center for MS and Autoimmune Neurology
Rochester, MN
Rochester, MN
MS centers in Minnesota
Compare treatment centers near a trial site by center type, providers and trials.
View Minnesota centersMore Phase 2 trials
Browse all Phase 2 MS trialsThe app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.